FINWIRES · TerminalLIVE
FINWIRES

Arch Biopartners Receives Review Board Approval Ahead of Phase 2 LSALT Trial Expansion

By

Arch Biopartners (ARCH.V) has received central Institutional Review Board (IRB) for the Phase 2 LSALT peptide trial, the company said on Monday.

The trial targets cardiac surgery-associated acute kidney injury (CS-AKI) and the study is expanding into the US. The central IRB approval is key for activating the sites there, Arch said.

The company is also adding one more Canadian site to the Phase 2 trial.

"The US expansion is an important part of our development strategy for LSALT peptide and the CS-AKI program," said Chief Executive Officer Richard Muruve. "For Arch, it is also a strategic step toward establishing a stronger global presence as we advance our clinical-stage kidney programs."

It is expected that the US clinical sites will require four to six months of preparation before dosing their first patient.

Arch Biopartners shares were last seen down C$0.06 at C$1.03 on the TSX Venture Exchange.

Price: $1.03, Change: $-0.06, Percent Change: -5.50%

What else is happening in Mining & Metals?

Mining & Metals

Tree Island Steel Says Chief Operating Officer Nancy Davies to Retire on Oct. 1. Chief Financial Officer Brian Liu to Replace Davies in The Role But Will Also Continue As CFO Until A Repl

$TSL.TO
Mining & Metals

B2Gold Reports Fatality at Philippines Gold Mine

B2Gold (BTO.TO) after trade Friday reported a fatality at its Masbate Gold Project in the Philippines.The employee was performing scheduled maintenance at the water treatment plant when a pipe burst, causing a fatal injury, the company said.The company said it has stopped work in the affected area and launched an investigation into the incident."Mining and processing activities continue uninterrupted. The company will provide additional information when appropriate," it added.

$BTO.TO
Mining & Metals

Energy Fuels Completes Australian Strategic Materials Deal to Expand Rare Earth Platform

Energy Fuels (EFR.TO) after trade Friday said it completed its acquisition of Australian Strategic Materials (ASM)."The acquisition of ASM marks a major milestone in Energy Fuels' long-term growth strategy to build an integrated mine-to-magnet rare earth platform," the company said.The deal adds ASM's operating Korean Metals Plant, giving Energy Fuels immediate metal and alloy production capacity. The plant currently produces 1,300 tonnes per year of neodymium-iron-boron alloy and is being expanded to 3,600 tonnes per year, with completion expected by the end of 2026, the company said.Along with Energy Fuels' heavy mineral sands projects in Brazil, Australia, and Madagascar, the ASM deal strengthens the company's position across mining, processing, oxides, metals, and alloys "creating a robust platform for its planned entry into permanent magnet production", it added.Following the transaction, ASM shares were delisted from the ASX, according to the statement.

$EFR.TO